People Are Still Having Sex. So Why Are S.T.D. Rates Dropping? - The New York Times
People Are Still Having Sex. So Why Are S.T.D. Rates Dropping? - The New York Times |
- People Are Still Having Sex. So Why Are S.T.D. Rates Dropping? - The New York Times
- Sexually Transmitted Disease (STD) Testing Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue, Manufacturers | Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd. - Aerospace Journal
- Burlington County Health Department resuming HIV/STD testing - InsiderNJ
- Sexually Transmitted Disease (STD) Testing Market Segmentation Application, Technology & Market Analysis Research Report To 2025 - The Think Curiouser
| People Are Still Having Sex. So Why Are S.T.D. Rates Dropping? - The New York Times Posted: 28 Oct 2020 09:33 AM PDT  For the first time in years, rates of chlamydia, gonorrhea and syphilis, which had been on track in 2020 to hit record highs in the United States, have taken an abrupt downturn. This should be good news. The coronavirus pandemic has certainly kept more people away from bars, night clubs and large parties, reducing opportunities for unsafe sex, studies show. But the drop is more likely a harbinger of bad news, experts in reproductive and sexual health believe. They say the pandemic has seriously hindered efforts to mitigate sexually transmitted infections that can lead to pelvic inflammatory disease, chronic pain, infertility and even blindness and death in newborns. Rather than showing sexually transmitted diseases are on the run, the upbeat numbers likely signal instead that they are now going largely undetected. In communities across the country, contact tracers for gonorrhea and syphilis, which had already been severely understaffed, have been diverted to Covid-19 cases. Eighty percent of sexual health screening clinics reported having to reduce hours or shut down altogether sometime during the pandemic, according to a survey by the National Coalition of STD Directors. In New York City only one of eight facilities was open this spring; now just three are open, which are steadily busy, because they are more of a safety net service than ever, said Dr. Julia A. Schillinger, an assistant commissioner at the New York City health department. Doctors also believe that many patients who might otherwise seek treatment for S.T.D. symptoms have been avoiding the clinics for fear of being exposed to Covid-19. And in some regions, essential supplies to test for S.T.D.s are running low because manufacturers of swabs, tubes and reagents are redirecting their products for use in coronavirus tests. As a result, there is a growing shortage of tests for the diseases. "Our most effective tool for control is timely diagnosis and treatment," said Dr. Gail Bolan, director of the Division of S.T.D. Prevention at the Centers for Disease Control and Prevention. 'We're very concerned that we'll have continued, unchecked and sustained increases now if people can't access screening now." In short, desperate efforts to contain one pandemic could well inflame the spread of another. The C.D.C.'s preliminary 2019 figures, the sixth consecutive record year, indicate 1.76 million cases of chlamydia and 602,000 of gonorrhea. Cases of newborn syphilis alone increased 22 percent from 2018. Alarmed, officials at the C.D.C. issued alerts throughout the summer to clinicians nationwide. In its latest letter last month, the agency recommended that priorities for screening and testing should go to patients with symptoms, women who are under 25 or pregnant, and people at high risk for S.T.D.s, including those with H.I.V. Patients with chlamydia or gonorrhea are often asymptomatic; only testing, then, detects infection. But until the pandemic-related restrictions can be relaxed, the letter advised: "Routine screening visits should be deferred." Image  In the greater St. Louis area, only about 11 of 128 testing sites remained fully open this spring and summer, and in one health care system, testing dropped by 45 percent. Although many sites have begun to reopen, during one recent week, the St. Louis County Sexual Health Clinic had no urine test kits for gonorrhea and chlamydia, according to Dr. Hilary Reno, its medical director. Area hospitals had been on the hunt as well. One reason that public health officials believe that the drop reflects test shortages and limited clinic access rather than less sexual activity is that the rates of decrease are more pronounced in gonorrhea and chlamydia, for which the test supplies have been affected, rather than in syphilis and H.I.V., which are detected through blood tests. Dr. Bolan is also troubled by the breakdown in reporting of cases. "It's not just data for the purpose of collecting it," she said. "Surveillance is the backbone of public health. It's how we allocate our resources. Without timely and accurate data, we feel like we have blindfolds on, while trying to figure out where our hot spots are." Doctors and nurses who work in clinics that serve mostly poor and minority patients say that the burden of the extreme service cutbacks and lack of testing falls most heavily on them. Those who work with teenagers said that many clinics that distribute free condoms have closed. Dr. Joy Friedman directs adolescent medical services at the Einstein Medical Center, in a low-income neighborhood in Philadelphia. Teenagers tell her how difficult it is to discuss condom use with partners. Regular testing is the one way they have to protect themselves. And now, she said, "they need to know that testing won't be available." Despite considerable efforts to reduce S.T.D.s, reported cases at the beginning of 2020 were higher than those during the same period in 2019, according to the C.D.C. But by early March, as the nation began complying with stay-at-home orders, those levels plummeted. In early April, weekly reports of chlamydia were 53 percent below 2019 numbers, with both gonorrhea and syphilis down 33 percent. Gonorrheahad been expected to hit an April monthly total of 54,127. But only 26,771 cases were reported. As of mid-June, chlamydia numbers remained depressed but reporting of gonorrhea and syphilis had returned to expected rates. Given the limitations on testing and clinic closures, however, cases may well be higher. "If sexual behavior rebounds while service interruption persists, we project an excess of hundreds of H.I.V. cases and thousands of S.T.I. cases," researchers from Emory, Harvard and the University of North Carolina, Chapel Hill wrote in a preprint study of the sexual practices Atlanta men who had sex with men during the pandemic. Social scientists are exploring how the coronavirus outbreaks have affected sexual behavior. Justin Lehmiller, a social psychologist at the Kinsey Institute, which has been issuing surveys during the pandemic to about 2,000 people, gay, straight and bisexual, said that even those in continuing relationships reported having less sex in the first months. "Higher levels of stress and anxiety are pushing down desire," he said. "Singles have more challenges to hooking up." But when doctors and nurse practitioners who work with teenagers were asked if the pandemic had slowed down their patients' sexual activity, they replied that, anecdotally speaking, not at all. Dr. Bolan said that one New York pediatrician reported that she'd treated many teenagers for S.T.D.s. Even if sex has declined, researchers question how long it can remain suppressed. Dr. Lehmiller noted that online dating apps report record business. Whether that translates into sexual activity rather than virtual meet-ups is unclear, he said. If people are returning to normal levels of encounters, they may not want to admit it. "There is shaming about traveling, social events and gatherings during the pandemic, so sex and dating is seen as part of that," he said. The Coronavirus Outbreak ›Words to Know About TestingConfused by the terms about coronavirus testing? Let us help:
For now, triage at clinics is pervasive. Pre-pandemic, the San Francisco City Clinic would typically send more than a hundred specimens to be processed daily at the health department laboratory. Because those supplies have dwindled, the clinic is resorting to a smaller, more expensive backup system, that can only process several dozen gonorrhea and chlamydia tests a day, said Dr. Ina Park, an associate professor of community and family medicine at the University of California San Francisco School of Medicine. Men who take PrEP to prevent H.I.V. transmission should be screened for S.T.D.s every three months, but many clinics have spaced out those screenings to every six months, she said. A Michigan colleague who had run out of urine testing kits for chlamydia and gonorrhea, she said, was returning to techniques that had been replaced almost 20 years ago: "using older swabs that have to be placed a few centimeters inside the urethra of the penis and twirled around to obtain a specimen. It's highly unpleasant for the patient and doesn't encourage them to return for testing," Dr. Park said. "I'm concerned that this will worsen mistrust in the medical establishment, which is already an issue with some of the patients we serve," added Dr. Park, the author of "Strange Bedfellows," a book out in February on the history and science of sexually transmitted diseases. David C. Harvey, executive director of the National Coalition of STD Directors, said clinics are trying to come up with creative solutions, such as telemedicine visits. In a few districts where the biggest challenge is reduced clinic access, administrators are trying out test kits that allow patients to collect specimens at home, which they then mail to labs. And some clinics are working with pharmacies that can draw blood and have standing orders for some medications. Public health officials see these innovations as a silver lining that may continue after the pandemic abates. But for Dr. Friedman in Philadelphia, the current situation presents a social justice issue as well as a medical one. Her young, predominantly African-American and Latino patients, she said, have high rates of STDs because many do not have ready access to health care, and there is pervasive fear and distrust of medical institutions, which the inability to test for S.T.D.s is only exacerbating. "No one says we should curtail testing for Covid-19," Dr. Friedman said. "I don't understand why it has to be one or the other."  |
| Posted: 28 Oct 2020 04:07 AM PDT " " Sexually Transmitted Disease (STD) Testing Market 2020: Latest Analysis" Chicago, United States:- Global Sexually Transmitted Disease (STD) Testing Market reports offers important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion, acquisition, and new product launch as well as analyzing and understanding the market trends. Each segment of the global Sexually Transmitted Disease (STD) Testing market is extensively evaluated in the research study. The segmental analysis offered in the report pinpoints key opportunities available in the global Sexually Transmitted Disease (STD) Testing market through leading segments. The regional study of the global Sexually Transmitted Disease (STD) Testing market included in the report helps readers to gain a sound understanding of the development of different geographical markets in recent years and also going forth. We have provided a detailed study on the critical dynamics of the global Sexually Transmitted Disease (STD) Testing market, which include the market influence and market effect factors, drivers, challenges, restraints, trends, and prospects. The research study also includes other types of analysis such as qualitative and quantitative. Global Sexually Transmitted Disease (STD) Testing Market report offers a detailed Outlook and future prospects of the Industry. The Sexually Transmitted Disease (STD) Testing Market report includes various topics like market size & share, Product types, applications, key market drivers & restraints, challenges, growth opportunities, key players, competitive landscape. Top Players of Sexually Transmitted Disease (STD) Testing Market are Studied: Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd. Download Free Sample PDF (including full TOC, Tables, and Figures) of Sexually Transmitted Disease (STD) Testing Market Research 2020-2026:- @ Competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global Sexually Transmitted Disease (STD) Testing market to know the competition at both the domestic and global levels. Market experts have also offered the outline of every leading player of the global Sexually Transmitted Disease (STD) Testing market, considering the key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on the key factors such as company size, market share, market growth, revenue, production volume, and profits. NOTE:Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Sexually Transmitted Disease (STD) Testing Market which would mention How the Covid-19 is Affecting the Sexually Transmitted Disease (STD) Testing Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Sexually Transmitted Disease (STD) Testing Players to Combat Covid-19 Impact. According to Our Analyst, the Global Sexually Transmitted Disease (STD) Testing Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Sexually Transmitted Disease (STD) Testing market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report. Our exploration specialists acutely ascertain the significant aspects of the global Sexually Transmitted Disease (STD) Testing market report. It also provides an in-depth valuation in regards to the future advancements relying on the past data and present circumstance of Sexually Transmitted Disease (STD) Testing market situation. In this Sexually Transmitted Disease (STD) Testing report, we have investigated the principals, players in the market, geological regions, product type, and market end-client applications. The global Sexually Transmitted Disease (STD) Testing report comprises of primary and secondary data which is exemplified in the form of pie outlines, Sexually Transmitted Disease (STD) Testing tables, analytical figures, and reference diagrams. The Sexually Transmitted Disease (STD) Testing report is presented in an efficient way that involves basic dialect, basic Sexually Transmitted Disease (STD) Testing outline, agreements, and certain facts as per solace and comprehension. Segmentation by Application: Segmentation by Type: The Essential Content Covered in the Global Sexually Transmitted Disease (STD) Testing Market Report : * Top Key Company Profiles. Regional Coverage: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Some Main Reasons For Purchasing This Report: ✔ Readers of this report will receive in-depth knowledge about the market. ✔Updated statistics offered on the global Sexually Transmitted Disease (STD) Testing market report. ✔This report provides an insight into the market that will help you boost your company's business and sales activities. ✔It will help you to find prospective partners and suppliers. ✔It will assist and strengthen your company's decision-making processes. Get Full Customize report or for any Special Discount [email protected] @ https://www.reporthive.com/request_customization/2306032 Table of Contents Market Overview: This is the first section of the report that includes an overview of the scope of products offered in the global Sexually Transmitted Disease (STD) Testing market, segments by product and application, and market size. Market Competition by Player: Here, the report shows how the competition in the global Sexually Transmitted Disease (STD) Testing market is growing or decreasing based on deep analysis of market concentrate rate, competitive situations and trends, expansions, merger and acquisition deals, and other subjects. It also shows how different companies are progressing in the global Sexually Transmitted Disease (STD) Testing market in terms of revenue, production, sales, and market share. Company Profiles and Sales Data: This part of the report is very important as it gives statistical as well as other types of analysis of leading manufacturers in the global Sexually Transmitted Disease (STD) Testing market. It assesses each and every player studied in the report on the basis of main business, gross margin, revenue, sales, price, competitors, manufacturing base, product specification, product application, and product category. Market Status and Outlook by Region: The report studies the status and outlook of different regional markets such as Europe, North America, the MEA, Asia Pacific, and South America. All of the regional markets researched about in the report are examined based on price, gross margin, revenue, production, and sales. Here, the size and CAGR of the regional markets are also provided. Market by Product: This section carefully analyzes all product segments of the global Sexually Transmitted Disease (STD) Testing market. Market by Application: Here, various application segments of the global Sexually Transmitted Disease (STD) Testing market are taken into account for research study. Market Forecast: It starts with revenue forecast and then continues with sales, sales growth rate, and revenue growth rate forecasts of the global Sexually Transmitted Disease (STD) Testing market. The forecasts are also provided taking into consideration product, application, and regional segments of the global Sexually Transmitted Disease (STD) Testing market. Upstream Raw Materials: This section includes industrial chain analysis, manufacturing cost structure analysis, and key raw materials analysis of the global Sexually Transmitted Disease (STD) Testing market. Marketing Strategy Analysis, Distributors: Here, the research study digs deep into behavior and other factors of downstream customers, distributors, development trends of marketing channels, and marketing channels such as indirect marketing and direct marketing. Research Findings and Conclusion: This section is solely dedicated to the conclusion and findings of the research study on the global Sexually Transmitted Disease (STD) Testing market. Appendix: This is the last section of the report that focuses on data sources, viz. primary and secondary sources, market breakdown and data triangulation, market size estimation, research programs and design, research approach and methodology, and the publisher's disclaimer. Get Free Sample Copy of this report: https://www.reporthive.com/request_sample/2306032 Why Go For Report Hive Research? Sexually Transmitted Disease (STD) Testing Market Forecast, Sexually Transmitted Disease (STD) Testing Market Trends, Sexually Transmitted Disease (STD) Testing Market Research, Sexually Transmitted Disease (STD) Testing, Sexually Transmitted Disease (STD) Testing Market Analysis, Sexually Transmitted Disease (STD) Testing application, Sexually Transmitted Disease (STD) Testing Market CAGR Competitive Landscape, Sexually Transmitted Disease (STD) Testing Market Growth Get in Touch with Us : Report Hive Research Website: https://www.reporthive.com Email: [email protected] Speak to Research Analyst: +1-312-604-7084″  |
| Burlington County Health Department resuming HIV/STD testing - InsiderNJ Posted: 18 Oct 2020 12:00 AM PDT Burlington County Health Department resuming HIV/STD testing WESTAMPTON – The Burlington County Department of Health is resuming its confidential screening, testing and education services for HIV and other sexually transmitted diseases. These services are provided free of charge to county residents. Burlington County Health Director Dr. Herb Conaway said that the ongoing coronavirus pandemic has garnered huge amounts of attention, but that the spread of STDs is also a growing health concern. "Rates of STDS were already rising across the United States before the pandemic and we've heard from the U.S. Centers of Disease Control and Prevention that STD testing has plummeted during the pandemic," Dr. Conaway said. "It's a concern because while most of these illnesses are curable with antibiotics if caught early, they can cause more serious health consequences or even death if left untreated. And the last thing we want is another public health crisis on our hands. Also the CDC recommends that adults up to 64 years of age get tested for HIV at least once. HIV testing is done with a finger stick and is resulted in just 20 minutes during your visit." The testing is by appointment only and will resume on Oct. 20 and will be scheduled on Tuesdays between 3 to 5 PM and Wednesdays from 5 to 7 PM at the Health Department Building, 15 Pioneer Boulevard, Westampton. Appointments can be made online at the following URL: http://www.burlingtoncountytesting.org For patient safety and security photo identification and masks are required for anyone entering the Health Department Building for testing. (Visited 46 times, 1 visits today)  |
| Posted: 28 Oct 2020 12:52 PM PDT Sexually Transmitted Disease (STD) Testing market research report provides the details about Industry Chain structure, Market Competition, Market Size and Share, SWOT Analysis, Technology, Cost, Raw Materials, Consumer Preference, Development and Trends, Regional Forecast, Company and Profile and Product and Service. This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Global Sexually Transmitted Disease (STD) Testing market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. Request a Sample of Sexually Transmitted Disease (STD) Testing Market Research Report with 104 pages and Analysis of Top Key Players at https://www.insidemarketreports.com/sample-request/4/541179/Sexually-Transmitted-Disease-STD-Testing
The Global Sexually Transmitted Disease (STD) Testing Market focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information along with the raw materials, equipment and demands. Also the distribution channel of this market is analyzed. Through the tables and figure required reliable and valuable statistics has also shown for proper guidance and direction for investors and individuals. The Report is segmented by types Laboratory testing devices, POC testing devices and by the applications Hospital, Research institute, Clinic, Others,. The study objectives are:
Report Customization Global Sexually Transmitted Disease (STD) Testing Diagnostics Market, report can be customized according to your business requirements as we recognize what our clients want, we have extended 15% customization at no additional cost to all our clients for any of our syndicated reports. In addition to customization of our reports, we also offer fully tailored research solutions to our clients in all industries we track. Our research and insights help our clients in identifying compatible business partners. Buy this report online at https://www.insidemarketreports.com/buy-now/4/541179/Sexually-Transmitted-Disease-STD-Testing/single Purchase this Report now by availing up to 40% Discount and free consultation. Why Inside Market Reports:
For all your Research needs, reach out to us at: Email: [email protected] Phone: +1-617-230-0741  |
| You are subscribed to email updates from "std testing" - Google News. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
Comments
Post a Comment